For research teamsHelp me find a study
Back to all studies
CompletedNCT01435928

Lurasidone for schizophrenia

This study is completed in the United States, in France, in Italy, .... It is testing lurasidone for schizophrenia.

SchizophreniaDrugFrom 18 Years to 75 Years

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

Explore recruiting studies on this topic

Then choose your country and confirm availability with each study site.

In plain English

Key information made simple

What is this study testing?

This study is testing whether Lurasidone may be useful for adults experiencing schizophrenia.

What would participation involve?

Participants may receive Lurasidone, attend study visits with the research team. The protocol may also involve randomization, placebo, or a comparison group. The registry lists locations in France, in Italy, and in Russia.

Who is it mainly for?

This study appears to be mainly for adults with schizophrenia.

What should you check before joining?

Ask about the dose, safety monitoring, and possible side effects, whether there is placebo, randomization, or a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.

Your next step

Check the study details

Check the official source, then confirm these points with the research team.

View official study record (opens in a new tab)

  • Recruitment and eligibility

    Is a site open, and who can take part?

  • Visits and time

    Where are visits, can any be remote, and how much time is needed?

  • Costs and support

    What costs, reimbursement or compensation apply?

Before joining

Questions to ask before joining

Study clarity

Things to check before joining

Study start dateSeptember 2011
Recruitment status
Completed
Enrollment listed in the registry
676
Sponsor
Sumitomo Pharma America, Inc.
Sponsor type
Pharmaceutical company
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
United States, France, Italy, ...
Age range
From 18 Years to 75 Years
Official registry ID
NCT01435928
Official title
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study Of Lurasidone For The Maintenance Treatment Of Subjects With Schizophrenia

Ask HopeStage to help me review this study

This record does not confirm open recruitment. We can help you understand it and explore other studies.

Loading the security check...
Study ID: NCT01435928. We help you review the study, but cannot decide medical eligibility.

Check recruitment and locations

Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.

View official study record (opens in a new tab)

The overall study status can differ from each site's status. Open a country to see its locations and their registry status.

France · 5 sites
  • CHU Clermont-Ferrand - CMP B
    Clermont-Ferrand
    Site status: Not listed — confirm with the team
  • Centre Hospitalier Specialise du Jura - Centre Medico Psychiatric
    Dole
    Site status: Not listed — confirm with the team
  • Centre Hospitalier Guillaume Regnier
    Rennes
    Site status: Not listed — confirm with the team
  • Hopital Chalucet, Centre hospitalier intercommunal de toulon la Seyne sur mer (CHITS)
    Toulon
    Site status: Not listed — confirm with the team
  • Cabinet Medical
    Toulouse
    Site status: Not listed — confirm with the team
Italy · 3 sites
  • SC SPDC-Edificio n. 7, Ospedale S. Andrea
    La Spezia
    Site status: Not listed — confirm with the team
  • Dipartimento Salute Mentale ASL 1
    Massa
    Site status: Not listed — confirm with the team
  • A.O.U. Santa Chiara, U.O di Psichiatria 1 building n.4
    Pisa
    Site status: Not listed — confirm with the team
Russia · 6 sites
  • Regional Government Institution Kipetsk Regional Psychoneurology Hospital
    Lipetsk
    Site status: Not listed — confirm with the team
  • Limited Liability Company (LLC) Research Center for Treatment and rehabilitation "Phoenix"
    Rostov-on-Don
    Site status: Not listed — confirm with the team
  • City Psychoneurological Dispensary #7 (with Hospital)
    Saint Petersburg
    Site status: Not listed — confirm with the team
  • St. Petersburg State Budgetary Healthcare Institution City Psychoneurology Dispensary #7 (with in-patient dept.) (SPb SBHI CPNDD-7), at daycare facility #1
    Saint Petersburg
    Site status: Not listed — confirm with the team
  • St. Petersburg State Healthcare Institution (SPbSH) "City Psychiatric Hospital #6"
    Saint Petersburg
    Site status: Not listed — confirm with the team
  • St. Petersburg State Government Healthcare Institution City Psychiatric Hospital #4 (St. Petersburg Insane Asylum Distributor)
    Saint Petersburg
    Site status: Not listed — confirm with the team
Serbia · 6 sites
  • Institute of Mental Health
    Belgrade
    Site status: Not listed — confirm with the team
  • Military Medical Academy, Clinic for Psychiatry
    Belgrade
    Site status: Not listed — confirm with the team
  • Clinical Centre Kragujevac, Clinic for Psychiatry
    Kragujevac
    Site status: Not listed — confirm with the team
  • Clinical Centre Nis, Clinic for mental health protection
    Niš
    Site status: Not listed — confirm with the team
  • Specialized Hospital for psychiatric diseases "Sveti Vracevi"
    Novi Kneževac
    Site status: Not listed — confirm with the team
  • Clinical Centre Vojvodina, Clinic for Psychiatry
    Novi Sad
    Site status: Not listed — confirm with the team
Slovakia · 7 sites
  • Nemonnica s poliklinikou v Prievidzi so sidlom v Bojniciach, Psychiatricke oddelenie
    Bojnice
    Site status: Not listed — confirm with the team
  • Psychiatricka ambulancia Mentum, s.r.o.
    Bratislava
    Site status: Not listed — confirm with the team
  • Psychiatricka nemocnica Michalovce
    Michalovce
    Site status: Not listed — confirm with the team
  • PsychoLine s.r.o. Psychiatricka ambulancia
    Rimavská Sobota
    Site status: Not listed — confirm with the team
  • Psychiaticke oddelenie Vseobecna nemocnica Riimavska Sobota, NaP n.o.
    Rimavská Sobota
    Site status: Not listed — confirm with the team
  • Psychiatricke oddelenie, Nemocnica s poliklinikou sv. Barbory Roznava, a.s.
    Rožňava
    Site status: Not listed — confirm with the team
  • Centrum zdravia R. B.K. s.r.o. Psychiatricka ambulancia
    Svidník
    Site status: Not listed — confirm with the team
South Africa · 3 sites
  • Research Unit, Department of Psychiatry Free State Psychiatric Complex
    Bloemfontein
    Site status: Not listed — confirm with the team
  • Cape Trial Centre
    Cape Town, W. Cape
    Site status: Not listed — confirm with the team
  • Denmar Hospital Consulting Rooms
    Pretoria
    Site status: Not listed — confirm with the team
United States · 45 sites
  • Woodland Research Northwest
    Springdale, Arizona
    Site status: Not listed — confirm with the team
  • K&S Professional Research
    Little Rock, Arkansas
    Site status: Not listed — confirm with the team
  • Woodland International Research Group
    Little Rock, Arkansas
    Site status: Not listed — confirm with the team
  • Comprehensive Clinical Development Inc.
    Cerritos, California
    Site status: Not listed — confirm with the team
  • Diligent Clinical Trials
    Downey, California
    Site status: Not listed — confirm with the team
  • Synergy Escondido
    Escondido, California
    Site status: Not listed — confirm with the team
  • Collaborative Neuroscience Network, Inc.
    Garden Grove, California
    Site status: Not listed — confirm with the team
  • Axis Clinical Trials
    Los Angeles, California
    Site status: Not listed — confirm with the team
  • Synergy Clinical Research Center
    National City, California
    Site status: Not listed — confirm with the team
  • Excell Clinical Trials
    Oceanside, California
    Site status: Not listed — confirm with the team
  • CNRI - Los Angeles LLC,8309 Telegraph Road
    Pico Rivera, California
    Site status: Not listed — confirm with the team
  • California Neuropsychopharmacology Clinical Research Instit
    San Diego, California
    Site status: Not listed — confirm with the team
  • Neuropsychiatric Research Center of Orange County
    Santa Ana, California
    Site status: Not listed — confirm with the team
  • Collaborative Neuroscience Network Inc.
    Torrance, California
    Site status: Not listed — confirm with the team
  • Florida Clinical Research Center, LLC
    Bradenton, Florida
    Site status: Not listed — confirm with the team
  • Accurate Clinical Trials
    Kissimme, Florida
    Site status: Not listed — confirm with the team
  • Florida Clinical Research Center, LLC
    Maitland, Florida
    Site status: Not listed — confirm with the team
  • Galiz Research
    Miami Springs, Florida
    Site status: Not listed — confirm with the team
  • Medical Research Group of Central Florida
    Orange City, Florida
    Site status: Not listed — confirm with the team
  • Atlanta Center for Medical Research
    Atlanta, Georgia
    Site status: Not listed — confirm with the team
  • Comprehensive NeuroScience, Inc.
    Atlanta, Georgia
    Site status: Not listed — confirm with the team
  • Lake Charles Clinical Trials
    Lake Charles, Louisiana
    Site status: Not listed — confirm with the team
  • Lousiana Clinical Research, LLC
    Shreveport, Louisiana
    Site status: Not listed — confirm with the team
  • CBH Health LLC
    Rockville, Maryland
    Site status: Not listed — confirm with the team
  • Psychiatric Care and Research Center
    O'Fallon, Missouri
    Site status: Not listed — confirm with the team
  • Psych Care Consultants Research
    St Louis, Missouri
    Site status: Not listed — confirm with the team
  • Horne Research
    Las Vegas, Nevada
    Site status: Not listed — confirm with the team
  • Center for Psychiatry and Behavioral Medicine, Inc.
    Las Vegas, Nevada
    Site status: Not listed — confirm with the team
  • CRI Worldwide LLC
    Willingboro, New Jersey
    Site status: Not listed — confirm with the team
  • University of New York, Dept. of Psychiatry
    Buffalo, New York
    Site status: Not listed — confirm with the team
  • Neurobehavioral Research, Inc.
    Cedarhurst, New York
    Site status: Not listed — confirm with the team
  • Comprehensive Clinical Development, Inc
    Fresh Meadows, New York
    Site status: Not listed — confirm with the team
  • Finger Lakes Clinical Research
    Rochester, New York
    Site status: Not listed — confirm with the team
  • Behavioral Medical Research of Staten Island
    Staten Island, New York
    Site status: Not listed — confirm with the team
  • Cutting Edge Research Group
    Oklahoma City, Oklahoma
    Site status: Not listed — confirm with the team
  • Oklahoma Clinical Research
    Oklahoma City, Oklahoma
    Site status: Not listed — confirm with the team
  • CRI Worldwide LLC at Kirkbride
    Philadelphia, Pennsylvania
    Site status: Not listed — confirm with the team
  • Lincoln Research
    Lincoln, Rhode Island
    Site status: Not listed — confirm with the team
  • Community Clinical Research, Inc.
    Austin, Texas
    Site status: Not listed — confirm with the team
  • FutureSearch Clinical Trials LP
    Austin, Texas
    Site status: Not listed — confirm with the team
  • FutureSearch Clinical Trials, LP
    Dallas, Texas
    Site status: Not listed — confirm with the team
  • Pillar Clinical Research LLC
    Dallas, Texas
    Site status: Not listed — confirm with the team
  • Family Psychiatry of the Woodlands
    The Woodlands, Texas
    Site status: Not listed — confirm with the team
  • Department of Psychiatry, University of Utah Health Sciences Center
    Salt Lake City, Utah
    Site status: Not listed — confirm with the team
  • Frontier Institute
    Spokane, Washington
    Site status: Not listed — confirm with the team
In practice

For you

Participation may contribute to research. Personal benefit is not guaranteed.

Ask the research team to explain the activities, time commitment, and follow-up involved.

Study sites are listed. Confirm the relevant site and any travel before making plans.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com

FAQ

Questions about this study

What is this study trying to understand?

This study is exploring medication or study treatment for people with schizophrenia. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.

Does this study involve a medication?

This appears to be a medication / drug study involving Lurasidone, Matching Placebo. Phase 3 studies are usually larger and aim to confirm effectiveness and safety in a broader group.

Who might this study be for?

This study may concern people with schizophrenia; age range: From 18 Years to 75 Years. The criteria appear fairly broad, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.

What would I likely need to do?

You may need to take a study treatment and have regular medical follow-up. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.

What side effects, interactions, or treatment changes should I check?

If the study involves a medication, ask whether it is already approved, experimental, or being tested for a new use. Check possible side effects, interactions with current treatment, dose changes, monitoring, and what happens if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.

Will I need to travel or attend in-person visits?

The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.

Who is behind this study?

This study is sponsored by Sumitomo Pharma America, Inc., which appears to be a pharmaceutical company. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.

Can I still join this study?

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me
Related studies

Explore related studies

Other studies that may be relevant based on condition, country, or study type.